Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A116P8 | ISIN: NL0010801007 | Ticker-Symbol: INX
Tradegate
29.04.24
08:15 Uhr
143,40 Euro
+1,50
+1,06 %
Branche
Chemie
Aktienmarkt
AEX
STOXX Europe 600
1-Jahres-Chart
IMCD NV Chart 1 Jahr
5-Tage-Chart
IMCD NV 5-Tage-Chart
RealtimeGeldBriefZeit
141,40143,3508:22
142,20143,4008:22
GlobeNewswire (Europe)
476 Leser
Artikel bewerten:
(2)

IMCD N.V.: IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market

ROTTERDAM, The Netherlands (10 January 2024) - IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces the acquisition of 70% of Valuetree Ingredients Private Limited ("Valuetree") to expand its beauty and personal care footprint in India.

Founded in 2005, Valuetree, is a prominent ingredient supplier to the beauty and personal care market. It provides an extensive portfolio of specialty ingredients and through an in-house application laboratory, offers formulation and technical support to its customers. Valuetree employs a team of 44 employees and generated a revenue of approximately INR 4.4 billion (ca. EUR 48 million) in the financial year that ended on March 31, 2023.

"As the beauty and personal care market in India continues to experience double-digit growth, acquiring Valuetree perfectly fits in our global strategy, it significantly enhances our capabilities and enriches our product portfolio. It further enhances our position as a leading solution provider in India," said Narendra Varde, Managing Director, IMCD India & Bangladesh.

"In a market dominated by large players, and now witnessing the emergence of direct to consumer (D2C) brands, our focus has been on customer centricity and providing innovative solutions. We are delighted that IMCD has partnered with us in Valuetree's next phase of growth," affirmed, Shailesh Karwa & Sharad Dalmia, co-founders of Valuetree, in a joint statement.

The transaction will take place in two tranches, with IMCD now acquiring 70% of the share capital from the founders and the remaining 30% to be acquired in 2025. The founders of Valuetree will continue to lead the company post-completion of this first tranche.

Attached, please find the full press release in PDF format, the main visual and the photo caption.

Attachments

  • Photo caption_IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market (https://ml-eu.globenewswire.com/Resource/Download/20c465ac-1ce7-4839-a0f8-be084ab6d1ab)
  • Main image_IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market_ (https://ml-eu.globenewswire.com/Resource/Download/f599abb8-98d8-4c0a-b448-d79efd12e665)
  • Press Release_IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market (https://ml-eu.globenewswire.com/Resource/Download/61f98888-9f27-49d0-a5bd-c5e9c9eeaf52)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.